BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
BCL2在乳腺癌中的作用：一种跨分子亚型且与辅助治疗无关的良好预后标志物。
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6605736
Dawson, S-J; Makretsov, N; Blows, F M; Driver, K E; Provenzano, E; Le Quesne, J; Baglietto, L; Severi, G; Giles, G G; McLean, C A; Callagy, G; Green, A R; Ellis, I; Gelmon, K; Turashvili, G; Leung, S; Aparicio, S; Huntsman, D; Caldas, C; Pharoah, P
